Agreement signedAgreed 11 Aug 2023

Swiftmerge Acquisition Corp. /
HDL Therapeutics, Inc.

Swiftmerge and HDL End Merger Agreement

Buy side: Swiftmerge Acquisition Corp.
Buy sideSwiftmerge Acquisition Corp.
Target: HDL Therapeutics, Inc.
TargetHDL Therapeutics, Inc.
Source · 11 Aug 2023Source-verified
Buy side: Swiftmerge Acquisition Corp.
Buy sideSwiftmerge Acquisition Corp.
Target: HDL Therapeutics, Inc.
TargetHDL Therapeutics, Inc.
01 / BuyerSwiftmerge Acquisition Corp.
02 / TargetHDL Therapeutics, Inc.
Source-verified
01

What happened

Swiftmerge Acquisition Corp. and HDL Therapeutics, Inc. terminated their previously announced merger agreement by mutual agreement on Feb. 14, 2024.

No termination fee or other payment is due to either party.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Swiftmerge and HDL End Merger Agreement

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

    Source-verified
  2. Also stated

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.